Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 96 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 7862815

    Methods for inhibiting angiogenesis with inhibitors of proadrenomedullin N-terminal 20 peptide (PAMP)

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted
  2. US 7863282

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted
  3. US 7855214

    Fused cyclic systems useful as inhibitors of TEC family protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted
  4. US 7850970

    Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections

    The Regents of the University of Colorado · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted
  5. US 7851495

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted
  6. US 7846945

    Piperdine-based inhibitors of sodium glucose co-transporter 2 and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  7. US 7838531

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted
  8. US 7838517

    Compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted
  9. US 7834037

    5-lipoxygenase-activating protein (FLAP) inhibitors

    AMIRA PHARMACEUTICALS, INC. · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted
  10. US 7829561

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted
  11. US 2010280048

    Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase

    ASTRAZENECA R & D [SE] · Granted Nov 4, 2010 · Expires Oct 30, 2030

    granted
  12. US 7825154

    Small molecule inhibitors of botulinum neurotoxins

    The United States of America as represented by the Secretary of the Army · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted
  13. US 7825242

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted
  14. US 7820685

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  15. US 7820671

    Peptidomimetic protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  16. US 2010267717

    Novel Heterocyclic NF-kB Inhibitors

    4SC AG [DE] · Granted Oct 21, 2010 · Expires Oct 16, 2030

    granted
  17. US 7816352

    Apoptosis inhibitors

    The Regents of the University of California · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  18. US 7807659

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted
  19. US 7807689

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted
  20. US 7807781

    Inhibitors of serine protease activity and their use in methods and compositions for treatment of viral infections

    The Regents of the University of Colorado · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted
  21. US 7799753

    Bisubstrate inhibitors of protein tyrosine kinases as therapeutic agents

    State of Rhode Island and Providence Plantations · Granted Sep 21, 2010 · Expires Sep 16, 2030

    granted
  22. US 7795428

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  23. US 7795259

    Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  24. US 7795208

    Methods of using deacetylase inhibitors to promote cell differentiation and regeneration

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted